Also known as: Groupe Hospitalier Universitaire Paris psychiatrie & neurosciences
Highest phase reached
Phase 3
First clinical trial
Last known activity
Apr 30, 2020
No events for the selected filters.
Phase 3 (1 own, 0 via acquisition)
Studied for